Cart
0

World cancer immunotherapies market - Opportunities and Forecasts, 2017-2023

Get 20% Free Customization In This Report
LI_181466
Pages: NA
Dec 2018 | 558 Views
 
Author's : NA
Tables: NA
Charts: NA
 

Cancer Immunotherapies has brought an unprecedented change in the global cancer therapies market. Cancer immunotherapy can be defined as, the treatment that deploys the bodys immune system, by joining and boosting innate powers of the immune system to fight cancer.

Over the past few years, cancer immunotherapies have generated new waves of optimism in the global oncology market, unveiling huge untapped potential for the innovators. After years of jostling over how to use the bodys immune system against cancer, researchers are now spotting newer targets and mechanisms to overcome the loopholes of conventional therapies. On the back of properties such as, comparably long-lived effects, exquisite specificity and improved survival rates, cancer immunotherapies have marked a paradigm shift in cancer management, as compared to existing conventional therapies. This has subsequently addressed the high unmet need for targeted therapies with high specificity for cancer type and minimal or no side effects.

Over the next decade, immunotherapies are expected to replace conventional cancer therapies and garner a significant share in the global cancer market.
The key factors driving the global cancer immunotherapies market are rising incidences of cancer, minimal or no side effects offered by immunotherapies, enhanced survival periods, long-term effects and strong emerging pipeline of cancer immunotherapies. Other key market drivers are sedentary lifestyle, less recurrence chance of cancer, accelerated regulatory approvals and augmented R&D investments on immunotherapies. However, factors such as high cost, limited range of cancer indications and high innovation challenges are likely to restrain the market. For instance, an investors awareness about the range of indications is presently limited to melanoma, renal cancer, and lately non-small cell lung cancer (NCSLC).

To provide the detailed market understanding, the cancer immunotherapies market is segmented on the basis of technology, therapy type, application and geography. Based on technology, the market is segmented into genetic engineering, hybridoma technology, humanization of monoclonal antibodies and overcoming the HAMA response via modern technology. On the basis of therapy type, the market is segmented into monoclonal antibodies, cancer vaccines, checkpoint inhibitors, cytokine therapies, other immune system boosters and miscellaneous immunotherapies. Each therapy type is further segmented across different sub-categories listed in the key market segments section. Based on application, the market is categorized into melanoma, renal cancer, NSCLC and others. The report covers a geographic breakdown and a detailed analysis of each of the aforesaid segments across North America, Europe, Asia Pacific, and LAMEA.

Comprehensive competitive analysis and profiles of major market players such as Johnson & Johnson, AstraZeneca plc, GlaxoSmithKline plc, Merck & Co., Inc., Novartis AG, Pfizer, Inc., F. Hoffman-La Roche AG, Advaxis, Inc., Immunomedics, Inc. and others are also provided in the report.

KEY MARKET BENEFITS:

  • This report provides an extensive analysis of the current and emerging market trends and dynamics in the Global Cancer Immunotherapies market.
  • The report covers the detailed quantitative analysis of the current market and estimations through 2014-2020, which would enable the stakeholders to capitalize on prevailing market opportunities
  • Extensive investigation is done for the market by therapy type which instils a clear understanding of benefits offered by different types and sub-types of therapy, the evolving role of checkpoint inhibitors and vaccines, monoclonal antibodies and other immune system boosters
  • The studies evaluating competitive landscape and value chain has been taken into account in this report to help in understanding the competitive environment across the geographies
  • Competitive intelligence highlights the business practises followed by leading market players across geographies
  • A detailed SWOT analysis enables to study the internal environment of the leading companies for strategy formulation
  • The cancer immunotherapies market scenario is comprehensively analysed in accordance with the key regions

KEY MARKET SEGMENTS:

The Global Cancer Immunotherapies market segmentation is illustrated below:

Cancer Immunotherapies Market By Technology

  • Genetic engineering
  • Hybridoma technology
  • Humanization of monoclonal antibodies
  • Overcoming the HAMA response via modern technology
  • Other latest technologies

Cancer Immunotherapies Market By Therapy Type

  • Monoclonal Antibodies
    • Approved Monoclonal Antibodies
    • New Monoclonal Antibodies
  • Cancer Vaccines
    • Tumor cell vaccines
    • Antigen vaccines
    • Dendritic cell vaccines
    • Vector-based vaccines
  • Checkpoint inhibitors
    • Programmed Death (PD-1) inhibitors
    • Cytotoxic T-lymphocyte antigen-4 (CTLA-4) inhibitors
    • TIM3 (T-cell Immunoglobulin and Mucin domain 3) inhibitors
    • LAG3 (Lymphocyte-activation gene or CD223) inhibitors
  • Cytokine therapy
    • Interferon
    • Interleukin
  • Other immune system boosters
    • Chimeric antigen receptor (CAR) T-cell therapy
    • Tumor-infiltrating lymphocytes and interleukin-2 (IL-2)
  • Miscellaneous Immunotherapies

Cancer Immunotherapies Market By Application

  • Melanoma
  • Prostate cancer
  • NSCLC
  • Others

Cancer Immunotherapies Market By Geography

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • U.K
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • Australia
    • China
    • India
    • Rest of Asia
  • LAMEA
    • Latin America
    • Middle East & Africa
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request TOC/Sample

Request Customization

Request TOC/Sample

OR

Purchase Full Report of
World cancer immunotherapies market - Opportunities and Forecasts, 2014 - 2022- Opportunities and Forecasts, 2014 - 2022

  • Online Only
  • $3456 $3111
  • Online cloud Access only
  • Restricted Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $3840 $3456
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5370 $4833
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6450 $5805
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprise
    License/PDF

  • $8995 $8096
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo